
    
      To compare the incidence of contrast-induced nephropathy (CIN)(an absolute SCr increase 0.5
      mg/dL from baseline) following the administration of iopamidol-370 (Iopamiro-370) and
      iodixanol-320 (Visipaque 320) in patients with chronic kidney disease (serum creatinine level
      more than 1.5 mg/dL for men and more than 1.3 mg/dL for women or preprocedural estimated
      glomerular Ô¨Åltration rate(eGFR):15-60 mL/min/1.73 m2) undergoing coronary angiography.
    
  